Literature DB >> 25447675

Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.

Mariya O Krisenko1, Robert L Geahlen2.   

Abstract

SYK (spleen tyrosine kinase) is well-characterized in the immune system as an essential enzyme required for signaling through multiple classes of immune recognition receptors. As a modulator of tumorigenesis, SYK has a bit of a schizophrenic reputation, acting in some cells as a tumor promoter and in others as a tumor suppressor. In many hematopoietic malignancies, SYK provides an important survival function and its inhibition or silencing frequently leads to apoptosis. In cancers of non-immune cells, SYK provides a pro-survival signal, but can also suppress tumorigenesis by restricting epithelial-mesenchymal transition, enhancing cell-cell interactions and inhibiting migration.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Epithelial–mesenchymal transition; Protein phosphorylation; SYK; Signal transduction; Spleen tyrosine kinase

Mesh:

Substances:

Year:  2014        PMID: 25447675      PMCID: PMC4254495          DOI: 10.1016/j.bbamcr.2014.10.022

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  124 in total

1.  Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Authors:  R G Caldwell; J B Wilson; S J Anderson; R Longnecker
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

2.  A public database for gene expression in human cancers.

Authors:  A Lal; A E Lash; S F Altschul; V Velculescu; L Zhang; R E McLendon; M A Marra; C Prange; P J Morin; K Polyak; N Papadopoulos; B Vogelstein; K W Kinzler; R L Strausberg; G J Riggins
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

3.  Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.

Authors:  Yunfei Yuan; Jianping Wang; Jinqing Li; Li Wang; Meixiang Li; Zuli Yang; Changqing Zhang; Jia Le Dai
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

4.  Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.

Authors:  M Turner; P J Mee; P S Costello; O Williams; A A Price; L P Duddy; M T Furlong; R L Geahlen; V L Tybulewicz
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

5.  Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros.

Authors:  Fatih M Uckun; Hong Ma; Jian Zhang; Zahide Ozer; Sinisa Dovat; Cheney Mao; Rita Ishkhanian; Patricia Goodman; Sanjive Qazi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

6.  Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.

Authors:  Tatsuya Toyama; Hirotaka Iwase; Hiroko Yamashita; Yasuo Hara; Yoko Omoto; Hiroshi Sugiura; Zhenhuan Zhang; Yoshitaka Fujii
Journal:  Cancer Lett       Date:  2003-01-10       Impact factor: 8.679

7.  Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion.

Authors:  R M Larive; S Urbach; J Poncet; P Jouin; G Mascré; A Sahuquet; P H Mangeat; P J Coopman; N Bettache
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

8.  β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis.

Authors:  Thomas Oellerich; Mark F Oellerich; Michael Engelke; Silvia Münch; Sebastian Mohr; Marika Nimz; He-Hsuan Hsiao; Jasmin Corso; Jing Zhang; Hanibal Bohnenberger; Tobias Berg; Michael A Rieger; Jürgen Wienands; Gesine Bug; Christian Brandts; Henning Urlaub; Hubert Serve
Journal:  Blood       Date:  2013-03-18       Impact factor: 22.113

9.  Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia.

Authors:  Fatih M Uckun; Sanjive Qazi; Ingrid Cely; Kazim Sahin; Anoush Shahidzadeh; Ibrahim Ozercan; Qian Yin; Paul Gaynon; Amanda Termuhlen; Jianjun Cheng; Seang Yiv
Journal:  Blood       Date:  2013-04-08       Impact factor: 22.113

10.  Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.

Authors:  Tatiana Perova; Ildiko Grandal; Lauryl M J Nutter; Eniko Papp; Irina R Matei; Joseph Beyene; Paul E Kowalski; Johann K Hitzler; Mark D Minden; Cynthia J Guidos; Jayne S Danska
Journal:  Sci Transl Med       Date:  2014-05-14       Impact factor: 17.956

View more
  45 in total

1.  SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.

Authors:  Gerald Moncayo; Michal Grzmil; Tatiana Smirnova; Pawel Zmarz; Roland M Huber; Debby Hynx; Hubertus Kohler; Yuhua Wang; Hans-Rudolf Hotz; Nancy E Hynes; Georg Keller; Stephan Frank; Adrian Merlo; Brian A Hemmings
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

2.  DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.

Authors:  C Pistore; E Giannoni; T Colangelo; F Rizzo; E Magnani; L Muccillo; G Giurato; M Mancini; S Rizzo; M Riccardi; N Sahnane; V Del Vescovo; K Kishore; M Mandruzzato; F Macchi; M Pelizzola; M A Denti; D Furlan; A Weisz; V Colantuoni; P Chiarugi; I M Bonapace
Journal:  Oncogene       Date:  2017-06-05       Impact factor: 9.867

3.  Entropic allostery dominates the phosphorylation-dependent regulation of Syk tyrosine kinase release from immunoreceptor tyrosine-based activation motifs.

Authors:  Chao Feng; Amitava Roy; Carol Beth Post
Journal:  Protein Sci       Date:  2018-10-02       Impact factor: 6.725

4.  Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer.

Authors:  Oksana Kowalczuk; Jerzy Laudanski; Wojciech Laudanski; Wieslawa Ewa Niklinska; Miroslaw Kozlowski; Jacek Niklinski
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

5.  Linking inflammation and cancer: the unexpected SYK world.

Authors:  Juan Fueyo; Marta M Alonso; Brittany C Parker Kerrigan; Candelaria Gomez-Manzano
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

6.  [Spleen tyrosine kinase inhibits proliferation and promotes apoptosis of colorectal cancer cells in vitro via regulating Fra-1].

Authors:  Zuo-Wu Xi; Wei-Tao Liang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

7.  Syk Is Recruited to Stress Granules and Promotes Their Clearance through Autophagy.

Authors:  Mariya O Krisenko; Reneé L Higgins; Soumitra Ghosh; Qing Zhou; Joy S Trybula; Wen-Horng Wang; Robert L Geahlen
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

8.  Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms.

Authors:  Lina Antenucci; Vesa P Hytönen; Jari Ylänne
Journal:  J Biol Chem       Date:  2018-02-12       Impact factor: 5.157

Review 9.  Recent advances and novel treatment paradigms in acute lymphocytic leukemia.

Authors:  Nikolaos Papadantonakis; Anjali S Advani
Journal:  Ther Adv Hematol       Date:  2016-06-29

10.  MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88.

Authors:  C Benito-Villalvilla; C Cirauqui; C M Diez-Rivero; M Casanovas; J L Subiza; O Palomares
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.